首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

2048131

排卵預測試劑盒市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Ovulation Predictor Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F

出版日期: 2026年05月25日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球排卵預測試劑（OPK）市場預計將從 2025 年的 25.6 億美元大幅成長至 2031 年的 37.9 億美元，複合年成長率為 6.76%。

這些診斷工具旨在透過檢測尿液中黃體激素(LH) 的激增來確定最佳受孕期。推動市場成長的關鍵因素包括：與生育延遲和生活方式選擇相關的不孕症問題日益增多，以及消費者對便利、私密的居家監測解決方案的需求不斷成長。根據美國生殖醫學會 (ASRM) 的數據，到 2025 年，全球平均總合生育率為每位女性 2.2 個孩子，這凸顯了人口結構變化正在推動生育治療需求的成長。這些因素，加上全球對生殖健康意識的不斷提高，共同促進了市場的擴張。

市場概覽
預測期	2027-2031
市場規模：2025年	25.6億美元
市場規模：2031年	37.9億美元
複合年成長率：2026-2031年	6.76%
成長最快的細分市場	唾液
最大的市場	北美洲

儘管成長強勁，排卵試紙市場仍面臨諸多障礙。其中包括先進的數位化檢測系統成本高且供應有限，尤其是在開發中國家。這種經濟壁壘限制了注重預算的消費者廣泛接受該產品，因為他們認為一次性組件的持續成本過高。因此，這種價格差異構成了一項重大挑戰，儘管對不孕症治療產品的需求強勁，但仍可能阻礙整體市場滲透。

市場促進因素

推動排卵追蹤解決方案日益普及的主要動力之一是全球人們生育年齡延遲和晚育現象增多的趨勢。隨著越來越多的人為了追求教育和事業目標而推遲生育，自然受孕的最佳時間越來越短，因此精準定位排卵期至關重要。這種人口結構的變化，尤其是在自然受孕率隨年齡成長而下降的老齡化下，更需要高度精準的診斷工具來提高受孕幾率。例如，根據美國疾病管制與預防中心（CDC）於2025年7月發布的《2024年美國生育狀況》報告，整體生育率預計將下降1%，達到每1,000名15-44歲女性53.8個新生兒的歷史新低。自然生育率的下降與計劃懷孕時對排卵預測試劑盒的依賴性增強直接相關。

同時，人工智慧 (AI) 和智慧型手機連接技術的整合正在改變不孕症監測市場。製造商正在開發超越基礎化學反應試紙的複雜生態系統，分析基礎體溫和荷爾蒙水平變化等生理數據，並透過行動應用程式提供個人化建議。這種數位化進步正在吸引那些追求數據驅動生殖健康管理的現代消費者。例如，根據 Oura Health Oy 於 2025 年 9 月發布的最新數據，該公司智慧戒指的銷量在 2024 年超過 550 萬枚，年收入加倍多，超過 5 億美元。這主要得益於其先進的女性健康追蹤功能。這些創新正在推動整個產業的持續成長，Church & Dwight Co., Inc. 2024 年的淨收入成長 4.1%，達到 61 億美元，便印證了這一點。

市場挑戰

先進數位檢測系統的高成本和有限的普及程度，為全球排卵預測試劑盒市場帶來了巨大挑戰，尤其是在新興經濟體。這種價格差異直接阻礙了價格敏感型消費者獲得原本可獲得的先進不孕症監測工具。儘管人們對生殖健康的認知不斷提高，但耗材和複雜介面帶來的持續經濟負擔限制了低收入地區的市場滲透。因此，這些潛在高成長地區的銷售量仍然較低，阻礙了該行業充分發揮其人口潛力。

此外，許多開發中國家缺乏健全的醫療報銷體系，加劇了這項經濟障礙，迫使用戶自行承擔全部診斷費用。即使在已開發市場，也迫切需要補償機制來確保服務的可及性，例如，國家生育協會（RESOLVE）就曾倡導立法，力爭到2025年將生育保險覆蓋範圍擴大到260多萬人。在新興市場，由於缺乏類似的經濟保障，數位排卵預測工具高昂的初始成本和持續成本有效地阻礙了其廣泛應用，並抑制了整個產業的成長。

市場趨勢

家用實驗室級定量荷爾蒙監測的出現徹底改變了市場格局。使用者不僅可以偵測黃體激素(LH)，還能追蹤多種生物標記。與只能辨識 LH 高峰的傳統定性試紙不同，現代系統能夠精確測量雌酮-3-Glucuronic acid(E3G) 和孕烷-1,5-二磷酸Glucuronic acid(PdG) 等代謝物的濃度。這在確認排卵和評估整體月經週期健康狀況方面達到了臨床等級的準確性，從而能夠收集與臨床研究相媲美的大量生物學數據。這顯著提高了生育力預測的準確性，尤其適用於月經週期不規則的女性。例如，晨星公司 (Morningstar) 2026 年 1 月發表的報導《Mira 榮獲 CES 創新獎》顯示，Quanovate Tech 公司（Mira）的平台已收集了超過 3000 萬個真實世界的荷爾蒙資料點，表明這種高精度診斷工具已被消費者廣泛接受。

同時，直接面對消費者（DTC）的分銷和訂閱模式的興起，正在擴大這些先進生育輔助工具的獲取管道，繞過傳統的臨床管道。新創公司正在籌集大量創業投資，並利用這些資金擴展物流，提供持續配送服務。這使得使用者無需頻繁前往藥房即可進行持續檢測。資金的注入也推動了產品線向更廣泛的健康監測領域擴展，鞏固了排卵檢測套組從一次性購買轉向持續健康管理平台的轉變。例如，在2025年12月的新聞稿中，Inito宣布完成2,900萬美元的B輪資金籌措，旨在將其家庭診斷功能擴展到生育以外的領域，這表明投資者對這種以消費者為中心的商業模式充滿信心。

The global market for Ovulation Predictor Kits (OPKs) is projected to expand significantly, rising from USD 2.56 billion in 2025 to USD 3.79 billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.76%. These diagnostic tools are specifically engineered to identify the most fertile period for conception by detecting the luteinizing hormone surge in urine. Key drivers of this market growth include an increasing incidence of fertility issues linked to delayed parenthood and lifestyle choices, coupled with a rising consumer demand for discreet and convenient at-home monitoring solutions. Data from the American Society for Reproductive Medicine in 2025, which reported a global average fertility rate of 2.2 births per woman, highlights the demographic shifts that are boosting the need for fertility assistance. These factors, alongside increasing global awareness of reproductive health, are collectively supporting the market's expansion.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 2.56 Billion
Market Size 2031	USD 3.79 Billion
CAGR 2026-2031	6.76%
Fastest Growing Segment	Saliva-Based
Largest Market	North America

Despite this robust growth, the OPK market faces a notable obstacle: the high cost and restricted availability of advanced digital testing systems, particularly in developing nations. This financial barrier limits broad adoption among budget-conscious consumers who may find the ongoing expenses for disposable parts too high. As a result, this gap in affordability poses a significant challenge, potentially hindering overall market penetration even with strong demand for fertility management products.

Market Driver

A major driving force behind the widespread use of ovulation tracking solutions is the global inclination towards delayed parenthood and pregnancies later in life. As individuals increasingly defer having children to pursue educational or career aspirations, the natural window for conception shrinks, making accurate identification of the fertile window crucial. This demographic shift necessitates highly precise diagnostic tools to enhance conception odds, especially as fertility naturally declines with age. For instance, the 'Births in the United States, 2024' report from the Centers for Disease Control and Prevention in July 2025 indicated a 1% drop in the general fertility rate to a record low of 53.8 births per 1,000 women aged 15-44, directly linking this reduction in natural birth rates to an increased dependence on predictor kits for planned conception.

Concurrently, the integration of Artificial Intelligence (AI) and smartphone connectivity into fertility monitors is transforming the market. Manufacturers are developing sophisticated ecosystems that go beyond basic chemical strips, analyzing physiological data like basal body temperature and hormone trends to deliver personalized insights through mobile applications. This digital evolution attracts contemporary consumers who desire data-driven management of their reproductive health. Oura Health Oy's September 2025 update, for example, highlighted that sales of its smart rings exceeded 5.5 million units, with annual revenue doubling to over $500 million in 2024, significantly boosted by advanced women's health tracking features. Such innovations, as reflected in Church & Dwight Co., Inc.'s 4.1% net sales increase to $6.1 billion in 2024, contribute to sustained financial growth throughout the sector.

Market Challenge

The high expense and restricted availability of advanced digital testing systems pose a significant challenge to the Global Ovulation Predictor Kits Market, especially in emerging economies. This affordability gap directly impedes access for price-sensitive consumers who might otherwise use sophisticated fertility monitoring tools. Despite increasing awareness of reproductive health, the ongoing financial strain from disposable components and advanced interfaces limits widespread market adoption in areas with lower disposable incomes. Consequently, sales volumes in these potentially high-growth regions remain low, hindering the sector from reaching its full demographic potential.

Furthermore, the absence of robust healthcare reimbursement systems in many developing countries exacerbates this financial hurdle, requiring users to pay for diagnostic costs entirely out-of-pocket. The critical need for coverage mechanisms to ensure accessibility is evident even in developed markets, as demonstrated by RESOLVE, the National Infertility Association, which in 2025 advocated for legislation to extend fertility insurance to over 2.6 million more individuals. Without similar financial safety nets in emerging markets, the substantial upfront and recurring costs of digital ovulation predictors effectively stall broader adoption and impede overall industry growth.

Market Trends

The market is undergoing a significant transformation with the emergence of lab-grade quantitative hormone monitoring for home use, allowing individuals to track a wide array of biomarkers beyond just detecting the luteinizing hormone (LH). In contrast to older qualitative strips that merely identify the LH surge, modern systems now precisely measure numerical concentrations of metabolites like Estrone-3-Glucuronide (E3G) and Pregnanediol Glucuronide (PdG). This provides clinical-level accuracy for confirming ovulation and evaluating overall cycle health, enabling the collection of extensive biological data comparable to clinical studies, which greatly improves fertility predictions, especially for those with irregular cycles. For instance, Morningstar's January 2026 article, 'Mira Named CES Innovation Awards Honoree,' noted that Quanovate Tech dba Mira's platform has gathered over 30 million real-world hormone data points, showcasing the widespread consumer adoption of these precise diagnostic tools.

Simultaneously, the growth of direct-to-consumer (DTC) distribution and subscription models is broadening access to these sophisticated fertility aids by circumventing traditional clinical pathways. Startups are attracting substantial venture capital, which they use to scale logistics and provide ongoing delivery services. This ensures users can maintain consistent testing without frequent pharmacy visits. This capital infusion also supports the expansion of product lines into more general health monitoring, solidifying the shift of ovulation kits from single purchases to continuous health management platforms. As an example, Inito's December 2025 press release announced a $29 million Series B funding round, aimed at extending its at-home diagnostic capabilities beyond fertility, thereby demonstrating strong investor confidence in this consumer-focused business approach.

Key Market Players

Swiss Precision Diagnostics GmbH
Church & Dwight Co., Inc.
Wondfo Biotech Co., Ltd.
Abbott Laboratories
Easy Healthcare Corporation
Fertility Focus Ltd.
Ava AG
Bongmi (Femometer)
ACON Laboratories, Inc.
Nantong Egens Biotechnology Co., Ltd.

Report Scope

In this report, the Global Ovulation Predictor Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ovulation Predictor Kits Market, By Type

Saliva-Based
Urine-Based

Ovulation Predictor Kits Market, By Application

Clinics
Diagnostic Centers
Fertility Centers
Home Care
Hospitals

Ovulation Predictor Kits Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ovulation Predictor Kits Market.

Available Customizations:

Global Ovulation Predictor Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ovulation Predictor Kits Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Saliva-Based, Urine-Based)
- 5.2.2. By Application (Clinics, Diagnostic Centers, Fertility Centers, Home Care, Hospitals)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Ovulation Predictor Kits Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Ovulation Predictor Kits Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Ovulation Predictor Kits Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Ovulation Predictor Kits Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Ovulation Predictor Kits Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Ovulation Predictor Kits Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. France Ovulation Predictor Kits Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Ovulation Predictor Kits Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Ovulation Predictor Kits Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Ovulation Predictor Kits Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia Pacific Ovulation Predictor Kits Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Ovulation Predictor Kits Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Ovulation Predictor Kits Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Ovulation Predictor Kits Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Ovulation Predictor Kits Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Ovulation Predictor Kits Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. Middle East & Africa Ovulation Predictor Kits Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Ovulation Predictor Kits Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. UAE Ovulation Predictor Kits Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. South Africa Ovulation Predictor Kits Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. South America Ovulation Predictor Kits Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Ovulation Predictor Kits Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Colombia Ovulation Predictor Kits Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. Argentina Ovulation Predictor Kits Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Ovulation Predictor Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Swiss Precision Diagnostics GmbH
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Church & Dwight Co., Inc.
15.3. Wondfo Biotech Co., Ltd.
15.4. Abbott Laboratories
15.5. Easy Healthcare Corporation
15.6. Fertility Focus Ltd.
15.7. Ava AG
15.8. Bongmi (Femometer)
15.9. ACON Laboratories, Inc.
15.10. Nantong Egens Biotechnology Co., Ltd.